Natural Capsules has announced a significant milestone in its growth journey with the strategic investment from Somerset Indus Capital Partners, a prominent healthcare-focused private equity fund. The investment involves the acquisition of a minority stake in Natural BioGenex Private Limited (NBPL), an unlisted subsidiary of Natural Capsules Limited.
Enforcement Report - Week of July 15
Somerset Therapeutics Generic Suxamethonium chloride Receives Approval in U.S
Somerset Therapeutics` Generic Dorzolamide Hydrochloride, Timolol Maleate Receives Approval In US
Somerset Therapeutics` Generic Bimatoprost Receives Approval in US
Somerset Theraps` Generic Dexamethasone Sodium Phosphate Receives Approval in US
Somerset`s Generic Dexamethasone Sodium Phosphate Receives Approval in US
Somerset Theraps` Generic Brimonidine Tartrate Receives Approval in US
What Endo thought was a real deal has turned into a kill deal.The Dublin-based Endo and its Par sterile injectables subsidiaries Wednesday said a $190 million agreement to buy sterile injectables company Somerset Therapeutics had been terminated without penalties because it was taking too long to complete.
Somerset Theraps` Generic Cisatracurium besylate Receives Approval in US